RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Partha Bhattacharjee to Herpesvirus 1, Human

This is a "connection" page, showing publications Partha Bhattacharjee has written about Herpesvirus 1, Human.
Connection Strength

3.377
  1. Hill JM, Nolan NM, McFerrin HE, Clement C, Foster TP, Halford WP, Kousoulas KG, Lukiw WJ, Thompson HW, Stern EM, Bhattacharjee PS. HSV-1 latent rabbits shed viral DNA into their saliva. Virol J. 2012 Sep 28; 9:221.
    View in: PubMed
    Score: 0.420
  2. Bhattacharjee PS, Neumann DM, Hill JM. A human apolipoprotein E mimetic peptide effectively inhibits HSV-1 TK-positive and TK-negative acute epithelial keratitis in rabbits. Curr Eye Res. 2009 Feb; 34(2):99-102.
    View in: PubMed
    Score: 0.326
  3. Bhattacharjee PS, Neumann DM, Foster TP, Clement C, Singh G, Thompson HW, Kaufman HE, Hill JM. Effective treatment of ocular HSK with a human apolipoprotein E mimetic peptide in a mouse eye model. Invest Ophthalmol Vis Sci. 2008 Oct; 49(10):4263-8.
    View in: PubMed
    Score: 0.311
  4. Bhattacharjee PS, Neumann DM, Foster TP, Bouhanik S, Clement C, Vinay D, Thompson HW, Hill JM. Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1. Exp Eye Res. 2008 Aug; 87(2):122-30.
    View in: PubMed
    Score: 0.310
  5. Bhattacharjee PS, Neumann DM, Stark D, Thompson HW, Hill JM. Apolipoprotein E modulates establishment of HSV-1 latency and survival in a mouse ocular model. Curr Eye Res. 2006 Sep; 31(9):703-8.
    View in: PubMed
    Score: 0.276
  6. Muniruzzaman S, McIntosh M, Hossain A, Izumori K, Bhattacharjee PS. A novel rare sugar inhibitor of murine herpes simplex keratitis. J Pharmacol Sci. 2016 Jun; 131(2):126-30.
    View in: PubMed
    Score: 0.135
  7. Hill JM, Stern EM, Bhattacharjee PS, Malamud D, Clement C, Rodriguez P, Lukiw WJ, Ochoa AC, Foster TP, Velasco C, McFerrin HE. The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model. Antiviral Res. 2013 Oct; 100(1):14-9.
    View in: PubMed
    Score: 0.111
  8. Webre JM, Hill JM, Nolan NM, Clement C, McFerrin HE, Bhattacharjee PS, Hsia V, Neumann DM, Foster TP, Lukiw WJ, Thompson HW. Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseases. J Biomed Biotechnol. 2012; 2012:612316.
    View in: PubMed
    Score: 0.105
  9. Al-Dujaili LJ, Clerkin PP, Clement C, McFerrin HE, Bhattacharjee PS, Varnell ED, Kaufman HE, Hill JM. Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated? Future Microbiol. 2011 Aug; 6(8):877-907.
    View in: PubMed
    Score: 0.097
  10. Clement C, Bhattacharjee PS, Kumar M, Foster TP, Thompson HW, Hill JM. Upregulation of mouse genes in HSV-1 latent TG after butyrate treatment implicates the multiple roles of the LAT-ICP0 locus. Invest Ophthalmol Vis Sci. 2011 Mar; 52(3):1770-9.
    View in: PubMed
    Score: 0.095
  11. Kennedy DP, Clement C, Arceneaux RL, Bhattacharjee PS, Huq TS, Hill JM. Ocular herpes simplex virus type 1: is the cornea a reservoir for viral latency or a fast pit stop? Cornea. 2011 Mar; 30(3):251-9.
    View in: PubMed
    Score: 0.094
  12. Hobden JA, Kumar M, Kaufman HE, Clement C, Varnell ED, Bhattacharjee PS, Hill JM. In vitro synergism of trifluorothymidine and ganciclovir against HSV-1. Invest Ophthalmol Vis Sci. 2011 Feb; 52(2):830-3.
    View in: PubMed
    Score: 0.094
  13. Lukiw WJ, Cui JG, Yuan LY, Bhattacharjee PS, Corkern M, Clement C, Kammerman EM, Ball MJ, Zhao Y, Sullivan PM, Hill JM. Acyclovir or A?42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells. Neuroreport. 2010 Oct 06; 21(14):922-7.
    View in: PubMed
    Score: 0.091
  14. Kumar M, Kaufman HE, Clement C, Bhattacharjee PS, Huq TS, Varnell ED, Thompson HW, Hill JM. Effect of high versus low oral doses of valacyclovir on herpes simplex virus-1 DNA shedding into tears of latently infected rabbits. Invest Ophthalmol Vis Sci. 2010 Sep; 51(9):4703-6.
    View in: PubMed
    Score: 0.089
  15. Clement C, Bhattacharjee PS, Kaufman HE, Hill JM. Heat-induced reactivation of HSV-1 in latent mice: upregulation in the TG of CD83 and other immune response genes and their LAT-ICP0 locus. Invest Ophthalmol Vis Sci. 2009 Jun; 50(6):2855-61.
    View in: PubMed
    Score: 0.081
  16. Clement C, Popp MP, Bloom DC, Schultz G, Liu L, Neumann DM, Bhattacharjee PS, Hill JM. Microarray analysis of host gene expression for comparison between na?ve and HSV-1 latent rabbit trigeminal ganglia. Mol Vis. 2008 Jul 03; 14:1209-21.
    View in: PubMed
    Score: 0.078
  17. Toma HS, Murina AT, Areaux RG, Neumann DM, Bhattacharjee PS, Foster TP, Kaufman HE, Hill JM. Ocular HSV-1 latency, reactivation and recurrent disease. Semin Ophthalmol. 2008 Jul-Aug; 23(4):249-73.
    View in: PubMed
    Score: 0.078
  18. Hill JM, Ball MJ, Neumann DM, Azcuy AM, Bhattacharjee PS, Bouhanik S, Clement C, Lukiw WJ, Foster TP, Kumar M, Kaufman HE, Thompson HW. The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender. J Virol. 2008 Aug; 82(16):8230-4.
    View in: PubMed
    Score: 0.078
  19. Giordani NV, Neumann DM, Kwiatkowski DL, Bhattacharjee PS, McAnany PK, Hill JM, Bloom DC. During herpes simplex virus type 1 infection of rabbits, the ability to express the latency-associated transcript increases latent-phase transcription of lytic genes. J Virol. 2008 Jun; 82(12):6056-60.
    View in: PubMed
    Score: 0.077
  20. Neumann DM, Bhattacharjee PS, Giordani NV, Bloom DC, Hill JM. In vivo changes in the patterns of chromatin structure associated with the latent herpes simplex virus type 1 genome in mouse trigeminal ganglia can be detected at early times after butyrate treatment. J Virol. 2007 Dec; 81(23):13248-53.
    View in: PubMed
    Score: 0.074
  21. Neumann DM, Bhattacharjee PS, Hill JM. Sodium butyrate: a chemical inducer of in vivo reactivation of herpes simplex virus type 1 in the ocular mouse model. J Virol. 2007 Jun; 81(11):6106-10.
    View in: PubMed
    Score: 0.071
  22. Hill JM, Bhattacharjee PS, Neumann DM. Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease. Exp Eye Res. 2007 May; 84(5):801-11.
    View in: PubMed
    Score: 0.069
  23. Anand BS, Hill JM, Dey S, Maruyama K, Bhattacharjee PS, Myles ME, Nashed YE, Mitra AK. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model. Invest Ophthalmol Vis Sci. 2003 Jun; 44(6):2529-34.
    View in: PubMed
    Score: 0.055
  24. Marquart M, Bhattacharjee P, Zheng X, Kaufman H, Thompson H, Varnell E, Hill J. Ocular reactivation phenotype of HSV-1 strain F(MP)E, a corticosteroid-sensitive strain. Curr Eye Res. 2003 Mar-Apr; 26(3-4):205-9.
    View in: PubMed
    Score: 0.054
  25. Hill J, Patel A, Bhattacharjee P, Krause P. An HSV-1 chimeric containing HSV-2 latency associated transcript (LAT) sequences has significantly reduced adrenergic reactivation in the rabbit eye model. Curr Eye Res. 2003 Mar-Apr; 26(3-4):219-24.
    View in: PubMed
    Score: 0.054
  26. Miller C, Bhattacharjee P, Higaki S, Jacob R, Danaher R, Thompson H, Hill J. Herpesvirus quiescence (QIF) in neuronal cells VI: Correlative analysis demonstrates usefulness of QIF-PC12 cells to examine HSV-1 latency, reactivation and genes implicated in its regulation. Curr Eye Res. 2003 Mar-Apr; 26(3-4):239-48.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support